Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study

International Journal of Rheumatic Diseases

Volumn 20, Issue 8, 2017, Pages 1002-1008

  Zhang, Li ^a   Duan, Yu ^b   Zhang, Tian Ping ^b   Huang, Xiao Lei ^b   Li, Bao Zhu ^b   Ye, Dong Qing ^b   Wang, Jing ^b  

^a Anhui Medical College   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

fibrosis; pulmonary involvement; systemic sclerosis; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFUSING LUNG CAPACITY FOR CARBON MONOXIDE; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LUNG ARTERY PRESSURE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DISORDER; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY ARTERY SYSTOLIC PRESSURE; RESPIRATORY TRACT PARAMETERS; SYSTEMIC SCLEROSIS; VERY ELDERLY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INSUFFICIENCY; ADULT; ANALOGS AND DERIVATIVES; BLOOD; CHINA; MIDDLE AGED; RADIOIMMUNOASSAY;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; SCLERODERMA, SYSTEMIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84960192095     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12794     Document Type: Article

References (34)

1. Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117, 557–67.
2. Wei J, Bhattacharyya S, Tourtellotte WG et al. (2011) Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy. Autoimmun Rev 10, 267–75.
3. Baraut J, Michel L, Verrecchia F et al. (2010) Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis. Autoimmun Rev 10, 65–73.
4. Chizzolini C, Brembilla NC, Montanari E et al. (2011) Fibrosis and immune dysregulation in systemic sclerosis. Autoimmun Rev 10, 276–81.
5. Vacca A, Cormier C, Piras M et al. (2009) Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 36, 1924–9.
6. Touvier M, Deschasaux M, Montourcy M et al. (2015) Determinants of vitamin D status in Caucasian adults: influence of sun exposure, dietary intake, sociodemographic, lifestyle, anthropometric, and genetic factors. J Invest Dermatol 135 (2), 378–88.
7. Lucas RM, Gorman S, Geldenhuys S et al. (2014) Vitamin D and immunity. F1000prime Rep, 6, 118.
8. Veldman CM, Cantorna MT, DeLuca HF (2000) Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374 (2), 334–8.
9. Morgan JW, Kouttab N, Ford D et al. (2000) Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology 141 (9), 3225–34.
10. Lemire JM, Archer DC (1991) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87 (3), 1103–7.
11. Fernandes de Abreu DA, Eyles D, Feron F (2009) Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 34 (Suppl 1), S265–77.
12. Zerr P, Vollath S, Palumbo-Zerr K et al. (2015) Vitamin D receptor regulates TGF-β signalling in systemic sclerosis. Ann Rheum Dis 74 (3), e20.
13. Nagpal S, Na S, Rathnachalam R (2005) Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26 (5), 662–87.
14. Wu PW, Rhew EY, Dyer AR et al. (2009) 25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum 61 (10), 1387–95.
15. Wright TB, Shults J, Leonard MB et al. (2009) Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J Pediatr 155 (2), 260–5.
16. Szodoray P, Nakken B, Gaal J et al. (2008) The complex role of vitamin D in autoimmune diseases. Scand J Immunol 68, 261–9.
17. Zold E, Barta Z, Bodolay E (2011) Vitamin D deficiency and connective tissue disease. Vitam Horm 86, 261–86.
18. Kerr GS, Sabahi I, Richards JS et al. (2011) Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol 38 (1), 53–9.
19. Huisman AM, White KP, Algra A et al. (2001) Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 28 (11), 2535–9.
20. Calzolari G, Data V, Carignola R et al. (2009) Hypovitaminosis D in systemic sclerosis. J Rheumatol 36(12), 2844; author reply, 5.
21. Belloli L, Ughi N, Marasini B (2011) Vitamin D in systemic sclerosis. Clin Rheumatol 30 (1), 145–6.
22. Ibn Yacoub Y, Amine B, Laatiris A et al. (2012) Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatol Int 32 (10), 3143–8.
23. Atteritano M, Sorbara S, Bagnato G et al. (2013) Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS ONE 8 (6), e66991.
24. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23, 581–90.
25. LeRoy EC, Black CM, Fleischmajer R et al. (1988) Scleroderma(systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15, 202–5.
26. Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA et al. (2012) Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol 67 (5), 931–8.
27. Medsger TA Jr, Bombardieri S, Czjriak L et al. (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21 (Suppl 29), S42–6.
28. Seriolo B, Molfetta L, Cutolo M (2011) Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis. Clin Rheumatol 30 (3), 445–6.
29. Arnson Y, Amital H, Agmon-Levin N et al. (2011) Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev 10 (8), 490–4.
30. Caramaschi P, Dalla Gassa A, Ruzzenente O et al. (2010) Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol 29 (12), 1419–25.
31. Yuen SY, Rochwerg B, Ouimet J et al. (2008) Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions. J Rheumatol 35 (6), 1073–8.
32. Artaza JN, Norris KC (2009) Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 200 (2), 207–21.
33. Ramirez AM, Wongtrakool C, Welch T et al. (2010) Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J Steroid Biochem Mol Biol 118 (3), 142–50.
34. Willis BC, Liebler JM, Luby-Phelps K et al. (2005) Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166 (5), 1321–32.